Skip to main content
. Author manuscript; available in PMC: 2023 Aug 1.
Published in final edited form as: Eur J Cancer. 2023 Aug;189:112916. doi: 10.1016/j.ejca.2023.05.005

Table 1.

Number of patients assigned to each of the dose and number of DLTs observed after Phase I and after the expansion cohort part. The column “0.75 mg/kg -> 0.60 mg/kg” corresponds to the patients who have switched the dosing level part through the treatment.

Dose Levels 0.30 mg/kg 0.60 mg/kg 0.75 mg/kg 0.75 mg/kg -> 0.60 mg/kg
After Phase I 0/3 0/5 0/4 NA
After Expansion 0/3 1/9 4/15 0/16